The FDA's CRL to Merck (MRK) and its partner Daiichi Sankyo for the patritumab deruxtecan BLA is based on observations made on inspection of a...

NORTH CHICAGO, Ill., June 25, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it received a Complete Response Letter (CRL) from the U.S. Food...

BASKING RIDGE, N.J. & RAHWAY, N.J., June 26, 2024 – The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL)...

Parkinson’s disease is a neurological condition that primarily affects movement, causing symptoms such as tremors, stiffness, and balance problems....

LEADERS of some doctor organizations called on the Food and Drug Administration (FDA) to approve the 2nd generation dengue vaccine, as the country...

Millions of people around the world are affected by Parkinson’s Disease (PD), a debilitating condition where brain cells progressively break down....

Parkinson’s disease is a progressive neurological disorder that affects movement, causing symptoms like tremors, stiffness, and difficulty with...

The neurotransmitter dopamine is commonly known for its role in brain networks regulating pleasure and reward. But many people with disorders that...

FDA rejects Merck (MRK) and AbbVie's (ABBV) filings for pipeline candidates. AstraZeneca (AZN) and Novo Nordisk (NVO) announce study failures.

AbbVie (ABBV) is seeking approval for Tepkinly in the EU as a monotherapy for the treatment of adult patients with relapsed/refractory follicular...